- Home
- WNW vs QNRX Comparison
WNW vs QNRX Comparison
Compare WNW & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNW
- QNRX
- Stock Information
- Founded
- WNW 2015
- QNRX 2018
- Country
- WNW China
- QNRX United States
- Employees
- WNW N/A
- QNRX N/A
- Industry
- WNW Catalog/Specialty Distribution
- QNRX Medical/Dental Instruments
- Sector
- WNW Consumer Discretionary
- QNRX Health Care
- Exchange
- WNW Nasdaq
- QNRX Nasdaq
- Market Cap
- WNW 5.4M
- QNRX 4.8M
- IPO Year
- WNW 2020
- QNRX N/A
- Fundamental
- Price
- WNW N/A
- QNRX $8.19
- Analyst Decision
- WNW
- QNRX
- Analyst Count
- WNW 0
- QNRX 0
- Target Price
- WNW N/A
- QNRX N/A
- AVG Volume (30 Days)
- WNW 47.6K
- QNRX 134.4K
- Earning Date
- WNW 11-14-2025
- QNRX 11-06-2025
- Dividend Yield
- WNW N/A
- QNRX N/A
- EPS Growth
- WNW N/A
- QNRX N/A
- EPS
- WNW 9.06
- QNRX N/A
- Revenue
- WNW $158,485.00
- QNRX N/A
- Revenue This Year
- WNW N/A
- QNRX N/A
- Revenue Next Year
- WNW N/A
- QNRX N/A
- P/E Ratio
- WNW $0.23
- QNRX N/A
- Revenue Growth
- WNW N/A
- QNRX N/A
- 52 Week Low
- WNW $0.95
- QNRX $5.01
- 52 Week High
- WNW $70.00
- QNRX $54.95
- Technical
- Relative Strength Index (RSI)
- WNW N/A
- QNRX 57.03
- Support Level
- WNW N/A
- QNRX $7.19
- Resistance Level
- WNW N/A
- QNRX $7.92
- Average True Range (ATR)
- WNW 0.00
- QNRX 0.44
- MACD
- WNW 0.00
- QNRX 0.04
- Stochastic Oscillator
- WNW 0.00
- QNRX 82.59
About WNW Meiwu Technology Company Limited
Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.